[ XXXX and @entity460 metabolism and its hormonal regulation in chronic kidney failure].

@entity1 @entity3747 @entity175 @entity177 @entity460 @entity1985 @entity3151 @entity631 @entity461
In order to elucidate the blood serum @entity460 , inorganic @entity3151 , parathyroid hormone ( @entity461 ) and @entity175 (CT) content in the course of the development of @entity177 ( @entity177 ), 80 @entity1 with chronile @entity631 were examined. Of these, in 24 glomerular filtration (GF) was normal, whereas 56 had @entity177 of varying degree. Thirty-three out of the 80 @entity1 had the @entity1985 ( @entity1985 ). The parameters enumerated were also determined in 45 @entity1 with @entity177 treated by hemodialysis. In @entity1 without the @entity1985 , @entity3747 was discovered only at the final predialysis stage of @entity177 , while in the presence of the @entity1985 , it was detectable in normal GF and was aggravated as @entity177 progressed. The @entity461 level ascended if GF was lower than 40 ml/min, not correlating with @entity460 concentration in the serum. A direct correlation was disclosed between the @entity461 level and that of inorganic @entity3151 . The role of the latter in stimulation of @entity461 and CT secretion in @entity177 is discussed. In @entity1 treated by hemodialysis, the @entity461 level significantly rose with treatment time increase. There was also a tendency toward elevation of CT concentration. The activity of the osseous fraction of blood serum alkaline phosphatase in @entity1 treated by hemodialysis was increased in 61-84% of cases depending on the treatment period.
